PITCH GLOBAL
HEALTHCARE LEADERSHIP

PITCH GLOBAL has shown leadership in LifeScience, HealthTech, MedTech, MedDevice industry. Fostering advancements in the health sector is 50% of our mission statement.
Our highly acclaimed event series during JPM Heathcare conference is a welcome platform for the attending companies.
Our unique leadership in building a network of CVCs (many of whom invest in early-stage Lifesciences companies is unmatched. Pitch Global Alumni have gone on to raise substantial amount of capital.
We are also part of the NorCal funding and mentoring network, where we can provide for selected California companies mentorship that is free of charge to them and hence giving them access to best practices in fundraising as well as develop a strategy for Grants.
How it ALL Started
In 2018 we were approached by the lead manager of a development project within Ricoh. The company's management had understood that after spending $20M in development, that there was actually no home within the corporation, despite early customer traction. We helped Ricoh spin out their non-core Health Tech division into Eiga Health and found them a lead Investor.


$29M Raised
Secured major venture funding | Developed innovative Bio-CMOS platform | Expanded global R&D to three continents
We have benefited from the continuous support as well as the advice on Corporate and Business Strategy from
the TFG Mentors Kaustav Chaudhuri and Axel Tillmann


Working with Axel through the California Governor’s Office SBDC accelerator has been a real gift. Axel is insightful, candid, and brings a rare mix of strategic thinking and real-world perspective. He quickly understood the challenges my company was facing and offered guidance that was both practical and deeply thoughtful. His coaching has made a real difference — and I’m genuinely grateful for his support. If you get the chance to work with Axel, take it.
Michael Kokesch President & Chief Executive Officer
Attending representatives CVCs, VCs
Beyond household names like J&J, Mayo Clinic, and Bayer – each a repeat participant at our events – we have established ourselves as the premier destination for Lifesciences and Health Tech companies to connect with non-traditional tech investors. We uniquely bridge the gap to Corporate Venture Capital firms that hold a deep interest in Lifesciences and Health Tech – an opportunity many entrepreneurs overlook. For example, at our recent JPMorgan Annual Event, we showcased senior investors from elite funds such as LG Tech, Niterra Ventures, Agilent, and L’Oréal, whose portfolios consist of 50% or more dedicated to Health Tech. We remain the only platform consistently spotlighting these high-caliber investors, setting the stage for transformative partnerships in the industry.
































Sample Investor Speakers &
Featured Investors
THESE ARE NOT ALL THE ATTENDING INVESTORS
SCHEDULE DETAILS
Sample Agenda
We are always aiming to bring the most relevant content to our audience. This is includes highly influential investors.
All listings are subject matter to change.
1:00 PM - 1:30 PM
Event Check-in / Registration & Table Setup


1:30 PM - 1:32 PM
OPENING REMARKS
Laird Cagan, Super Angel with 12 IPO’s & Member Band of Angels,
He will briefly speak about Tibaray, his portfolio co.

1:30 PM - 1:47 PM
Keynote Interview
How Lifesciences cos can raise Funds from Family Offices
Dr Evgeny Zaytsev –5 Lifesciences IPO, Bering Capital, who used to work for Pitch Johnson’s AMC Family Office which helped Fund cos like Amgen, Biogen etc. He will be interviewed by Sasha Johnson of DoubleStar VC, our long term Board Member, who co-Founded Tim Draper/DFJ’s Eastern European Fund


1:47PM - 1:59 PM
FiRESIDE CHAT
How startups can build partnerships with Corporates like J&J
Interview with Angela Specht, Global Head, BARDA Alliances, J&J.


1:59 PM - 2:10 PM
FiRESIDE CHAT
How startups can approach CVC’s for Funding & Partnerships
Interview with Todd Stavish, Managing Partner, SRI Ventures, who will also introduce Synfini, one of his portfolio cos which is presenting as well.


2:10 PM - 2:22 PM
FiRESIDE CHAT
How Lifesciences cos can raise Funds from Angels
Dr Sammy Datwani, Dealflow Chair at Lifesciences Angels. At one of our online events, he met Savage Bio(now Averto Medical) after which Lifesciences Angels made an investment. Based on this investment and the Due Diligence Report led by Dr Chris Apfel, who they also met at another of our online event, an angel with a $ 1B + recent exit came along and invest $ 40 m and took their next round


2:22 PM -2:25 PM
Sponsor Interview
Shaija Dixit, CEO of Curio Digital Therapeutics


2:25 PM - 4:00 PM
ROUND I
Selected Startups present to CVCs/VCs/Angels


4:00 PM - 4:12 PM
Q&A Style Interview
Dr. Chris Apfel LifeScience Chair Keieitsu Forum


4:12 PM -4:24 PM
Key Investor Interview
How Lifesciences cos can raise Funds from Sovereigns/PE Funds
Interview of Ishan Kumar, Investor from Mubadala Health.


4:24 PM -4:38 PM
Key Investor Interview
How Health Tech/Lifesciences startups can approach Tech CVC’s for Funding& Partnership
Interview of Dong Su Kim (LG Technology Ventures)


4:38 PM -4:40 PM
Sponsor Interview
Presenter/Sponsor Reza Amin, CEO & Founder Bastion Health


4:40 PM - 5:40 PM
ROUND II
Selected Startups present to CVCs/VCs/Angels


5:40 PM - 5:52 PM
Closing Remarks (Q&A style)
Pitch Global Board Member, Thomas Kluz, Managing Director of Niterra Ventures


5:52PM - 6:30PM
Investor Networking

NOTE:
Our events might be taped (partially or fully) and/or photographs might be taken. Registering for the event implies consent to the pictures and footage to be used for promotional purposes by Pitch Global.
OUR TESTIMONIAL
Hear what they say about Pitch Global Events
Testimonials from entrepreneurs and investors who have experienced Pitch Global Events.



GET IN TOUCH
Contact us for further information.
We are sure you like to learn specifics about Pitch Global, or even the CVC Accelerator. Do not hesitate to contact us directly.
$40M raised
Jeffrey Etter Sr VP and Co-FounderInvited by Pitch Global's Founder, we pitched and secured a $250K investment through a strategic pairing with Dr. Sammy Datwani, Dealflow Chair of Lifesciences Angels. Our momentum continued at their next event, where we partnered with Dr. Chris Apfel, Lifesciences Co-Chair of Keiretsu Forum, resulting in a comprehensive Due Diligence Report. Later, a former colleague with a recent high-profile exit, impressed by the "smart money" from Lifesciences Angels and Keiretsu Forum’s validation, invested $40M, fully funding our next round.